The eClinical Forum is a global network of peers. It provides a non‐competitive environment for innovation, learning and collaboration in clinical research.



BoF Round-table: Master Protocol Trial Designs & Data Management Considerations

Thursday, Oct 29, 2020

Event date: 29/10/2020 Export event

BoF Round-table: Master Protocol Trial Designs & Data Management Considerations

Birds-of-a-Feather Round Table Discussion:  Master Protocol Trial Designs & Data Management Considerations

Date:  Thursday, Oct 29, 2020  Duration: One hour

Facilitator:   Sara Hale, Amgen

Open To: Staff from eClinical Forum member companies gratis  (If you are not an eCF member, please review our website www.eclinicalforum.org/membership for membership information or contact info@eclinicalforum.org )

Background: eClinical Forum webinar sessions focus on the details of a specific topic.  All participants are encouraged to share information and ask questions. Anyone from an eCF member company can participate, gratis. The facilitator will [try to] keep the subject on track and prompt discussion and information sharing.

For This Topic:  

Background --  Since the release of the FDA guidance for Adaptive Clinical Trial Design, many Sponsors have been working to enable Master Protocol trials. The MP designs includes 1. Basket Trial Design 2 Umbrella Trial Designs and Platform Trial Designs, which more complex in nature in that they are inclusive of multiple sub-studies within a single trial that within a traditional designs would have been separating out into separate trials. Making it necessary to consider fit-for-purpose strategic operational, process and system solutions.

Discussion -- In this session, we will be looking to discuss:

  • set up, conduct and lock challenges and best practices Sponsor are identifying, including but not limited to:
    • utilization of multiple clinical trial databases(CTDB) and data management plans (DMP) to support sub-protocols
    • utilization of Interactive Response Technology (IRT) across multiple CTDBs/sub-protocols
    • people resourcing and oversight considerations across sub-protocols

Time:  We sincerely apologize for the inconvenient time this is being offered in the APAC region. Because our facilitator is in California, we were limited with when we could offer this discussion.  This round-table discussion will start at UTC 1500.

eClinical Forum Members -- FOLLOW THIS LINK TO REGISTER: https://eclinicalforum.org/Forms/Master-Protocol

Non-Members -- please send an email to info@eclinicalforum.org to request information about becoming a member.

Rate this article:
No rating


Visit the Membership page to learn 
How To Become a Member
(Join the eClinical Forum and learn how to leverage existing and emerging technologies for electronic clinical trials. Access an eClinical community, member-only knowledge, events and forums)
«June 2021»
MEMBERS...Recordings Now Available | ICH E6 Guideline for  Good Clinical Practice (GPC) – Update on Progress

MEMBERS...Recordings Now Available | ICH E6 Guideline for Good Clinical Practice (GPC) – Update on Progress

Recordings Now Available | ICH E6 Guideline for Good Clinical Practice (GPC) – Update on Progress 

...public web conference, "ICH E6 Guideline for Good Clinical Practice (GCP) – Update on Progress," that was held on May 18 & 19 and organized by the International Council for Harmonisation (ICH) and convened by the Clinical Trials Transformation Initiative (CTTI).

...listen to the web conference recordings, view the slides of the full presentations, and watch this video about the ICH guideline development process. 

To stay up to date on the work to revise ICH E6, please visit the ICH web page.


Read more
eCF BoF Round-table: Utilization of Scribes for eCOA

eCF BoF Round-table: Utilization of Scribes for eCOA

This is a round-table discussion. Participants are encouraged to share experiences, make comments, ask questions, and contribute to the discussion. We will be discussing “The utilization of scribes is needed for the conduct of clinical assessments within eCOA.  Therefore, eCOA needs to be built in a manner that meets the regulatory requirements for scribing, to ensure all individuals participating in the assessment are audit trailed.”

Read more
"When should audit trail begin?"

"When should audit trail begin?"

Several members of the eClinical Forum's Regulatory Advisory Group have published an article in Applied Clinical Trials on "When should audit trail begin?"  It is a discussion of the regulatory history behind audit trails and its interpretation as it relates to clinical research data originating or residing in EDC or eCOA systems.

Link to article:  When Should the Audit Trail Begin? (appliedclinicaltrialsonline.com) 

We welcome feedback! Please send to: REG@eclinicalforum.org 

Read more

Upcoming events Events RSSiCalendar export